{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:58:46Z","timestamp":1789588726540,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejca.2022.05.019","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:11:04Z","timestamp":1655421064000},"page":"150-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial"],"prefix":"10.1016","volume":"171","author":[{"given":"Junsheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciqiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liulu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-7080","authenticated-orcid":false,"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2022.05.019_bib1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.05.019_bib2","first-page":"144","article-title":"Managing taxane toxicities","volume":"11","author":"Markman","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.05.019_bib3","first-page":"3633","article-title":"Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review","volume":"24","author":"Fernandes","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.05.019_bib4","first-page":"221","article-title":"Efficacy of additional dexamethasone administration for the attenuation of paclitaxel-associated acute pain syndrome","volume":"28","author":"Saito","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.05.019_bib5","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1200\/JCO.2010.33.0308","article-title":"Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1","volume":"29","author":"Loprinzi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.05.019_bib6","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1002\/cncr.27489","article-title":"Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: north Central Cancer Treatment Group trial N08C1","volume":"118","author":"Reeves","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.05.019_bib7","first-page":"274","article-title":"Glutamine does not prevent paclitaxel-associated myalgias and arthralgias","volume":"1","author":"Jacobson","year":"2003","journal-title":"J Support Oncol"},{"key":"10.1016\/j.ejca.2022.05.019_bib8","first-page":"315","article-title":"The efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer","volume":"17","author":"Yoshida","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.05.019_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/gyno.2001.6168","article-title":"Effects of shakuyaku-kanzo-to on muscle pain from combination chemotherapy with paclitaxel and carboplatin","volume":"81","author":"Yamamoto","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2022.05.019_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/gyno.1998.5226","article-title":"Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias","volume":"72","author":"Markman","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2022.05.019_bib11","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2004.99.298","article-title":"Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias","volume":"22","author":"Nguyen","year":"2004","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ejca.2022.05.019_bib12","first-page":"Cd004309","article-title":"Single dose oral etoricoxib for acute postoperative pain in adults","author":"Clarke","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2022.05.019_bib13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard.2006.059162","article-title":"Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis","volume":"66","author":"Reginster","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejca.2022.05.019_bib14","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: American society of clinical oncology clinical practice guideline update","volume":"33","author":"Smith","year":"2015","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ejca.2022.05.019_bib15","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2011.37.8364","article-title":"Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base","volume":"30","author":"Kirshner","year":"2012","journal-title":"J Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ejca.2022.05.019_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mus.21874","article-title":"Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy","volume":"43","author":"Park","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejca.2022.05.019_bib17","first-page":"1323","article-title":"NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim","volume":"26","author":"Kirshner","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.05.019_bib18","first-page":"8059","article-title":"Risk factor analysis for taxane-associated acute pain syndrome under the dexamethasone prophylaxis","volume":"29","author":"Saito","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ejca.2022.05.019_bib19","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1185\/030079907X219625","article-title":"Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial","volume":"23","author":"Matsumoto","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejca.2022.05.019_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/03009740410005728","article-title":"Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial","volume":"33","author":"Pallay","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ejca.2022.05.019_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/glia.23557","article-title":"Interleukin-1beta released by microglia initiates the enhanced glutamatergic activity in the spinal dorsal horn during paclitaxel-associated acute pain syndrome","volume":"67","author":"Yan","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.ejca.2022.05.019_bib22","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1080\/21655979.2021.1955560","article-title":"The protective effects of naproxen against interleukin-1\u03b2 (IL-1\u03b2)- induced damage in human umbilical vein endothelial cells (HUVECs)","volume":"12","author":"Wu","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.ejca.2022.05.019_bib23","doi-asserted-by":"crossref","first-page":"17202","DOI":"10.1074\/jbc.274.24.17202","article-title":"Dexamethasone alters arachidonate release from human epithelial cells by induction of p11 protein synthesis and inhibition of phospholipase A2 activity","volume":"274","author":"Yao","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2022.05.019_bib24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.65.4.964","article-title":"Dexamethasone promotes toxicity in U937 cells exposed to otherwise nontoxic concentrations of peroxynitrite: pivotal role for lipocortin 1-mediated inhibition of cytosolic phospholipase A2","volume":"65","author":"Tommasini","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ejca.2022.05.019_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNP.0b013e3182767d3b","article-title":"Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer","volume":"30","author":"Chen","year":"2013","journal-title":"J Clin Neurophysiol official publication of the American Electroencephalographic Society"},{"key":"10.1016\/j.ejca.2022.05.019_bib26","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.clinph.2019.03.035","article-title":"Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy","volume":"130","author":"Chen","year":"2019","journal-title":"Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922002982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922002982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:37:12Z","timestamp":1760733432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922002982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":26,"alternative-id":["S0959804922002982"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.05.019","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}